Low Estrogen Receptor (ER)–Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy - Concepedia

Concepedia

Publication | Open Access

Low Estrogen Receptor (ER)–Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy

DOI Full Paper Access

76

Citations

24

References

2018

Year

Alessandra Landmann, Daniel J. Farrugia, Li Zhu, Emilia J. Diego, Ronald R. Johnson, Atilla Soran, David J. Dabbs, Beth Z. Clark, Shannon L. Puhalla, Rachel C. Jankowitz,

American Journal of Clinical Pathology

Abstract

Low ER+ breast cancers are biologically similar to ER- tumors. Semiquantitative ER H-score is an important determinant of response to neoadjuvant chemotherapy.

References

	Year	Citations

Page 1